Ausgabe 3/2024
Inhalt (10 Artikel)
Chronic Obstructive Pulmonary Disease in Heart Failure: Challenges in Diagnosis and Treatment for HFpEF and HFrEF
Sergio Henrique Rodolpho Ramalho, André Luiz Pereira de Albuquerque
Catheter Ablation of Ventricular Tachycardia in Ischemic Heart Disease: What Is Known and New Perspectives
Pasquale Valerio Falzone, Sara Vazquez-Calvo, Ivo Roca-Luque
Economic Considerations of Cardiovascular Implantable Electronic Devices for The Treatment of Heart Failure
Christian Elsner, Simon Bettin, Roland Tilz, Dennis Häckl
Putting More Weight on Obesity Trials in Heart Failure
Josephine Harrington, Naveed Sattar, G Michael Felker, James L. Januzzi, Carolyn S. P. Lam, Neha J. Pagidipati, Ambarish Pandey, Harriette G. C. Van Spall, Darren K. McGuire
Pregnancy, Reproductive Factors, and Female Heart Failure Risk and Outcomes
Guillermo Moreno, Manuel Martínez-Sellés, María Jesús Vicente-Galán, Lourdes Vicent
Cellular Alterations in Immune Checkpoint Inhibitor Therapy-Related Cardiac Dysfunction
Lars Michel, Peter Ferdinandy, Tienush Rassaf
(Non)-Exertional Variables of Cardiopulmonary Exercise Testing in Heart Failure with and Without Cardiac Amyloidosis
Simon Wernhart, Lars Michel, Alexander Carpinteiro, Peter Luedike, Tienush Rassaf
Relevance of Cardiovascular Exercise in Cancer and Cancer Therapy-Related Cardiac Dysfunction
Simon Wernhart, Tienush Rassaf
Evaluation and Management of Hyponatremia in Heart Failure
Giulio M. Mondellini, Frederik H. Verbrugge
Non-Coding Ribonucleic Acids as Diagnostic and Therapeutic Targets in Cardiac Fibrosis
Samuel R. Olson, W. H. Wilson Tang, Chia-Feng Liu